What patellar tendinopathy actually is — and why it behaves differently

The classic presentation is straightforward: anterior knee pain that builds during jumping, landing, or loading the leg, then settles quickly with rest. Press a finger to the tip of the kneecap — that sharp, well-localised tenderness at the inferior pole of the patella is the hallmark of patellar tendinopathy, also called jumper's knee. It is an overuse injury of the patellar tendon rather than a joint or cartilage problem, and it is most common in basketball and volleyball players, though it affects active adults of all types.

What drives the pain matters for choosing treatment. A 2025 case-control study found no differences in endogenous pain inhibition or temporal summation between symptomatic athletes and healthy controls — the pain originates from local tissue pathology in the tendon itself, not from altered central pain processing. That finding shapes the entire treatment logic: pain-modulation approaches are not the right target; loading and biology are.

Diagnosis is clinical. The UK Defence Rehabilitation Delphi consensus confirms that advanced imaging is not required before starting treatment, though ultrasound or MRI may be useful later to guide injections or rule out a partial tear.

Throughout this article, severity and progress are tracked using the VISA-P score (Victorian Institute of Sport Assessment – Patella), a 0–100 questionnaire measuring pain and function. It is the standard outcome measure across all treatment pathways, so understanding it as shorthand is useful from the outset.

Two related diagnoses are worth distinguishing briefly: patellofemoral pain, which is felt underneath the kneecap rather than at its tip, and patellar tendon rupture, which is an acute structural failure rather than a chronic overuse condition.

Why physio is always the starting point

Exercise rehabilitation is not a placeholder while something more definitive is arranged — it is the treatment, backed by the strongest evidence available for this condition and endorsed by multiple expert consensus groups including the UK Defence Rehabilitation Delphi panel.

The approach that sits at the centre of that evidence is Heavy Slow Resistance Training (HSRT): progressive resistance exercises performed slowly through the tendon's full range, with loads heavy enough to place meaningful mechanical demand on the tissue. That demand stimulates collagen remodelling in the affected portion of the tendon. Eccentric loading programmes work along the same principle and have a longer evidence history; most structured physio programmes draw on both.

For patients who cannot yet tolerate high tendon loads — because pain is acute, or because deconditioning makes a full loading programme impractical — Low-Load Blood Flow Restriction Training (LL-BFRT) is a well-evidenced alternative. A 2025 randomised controlled trial found that LL-BFRT and HSRT produced comparable improvements in both pain and VISA-P score at 12 weeks and again at 52 weeks, making it a genuine clinical option rather than a stopgap.

Education and load management are built into the programme, not optional extras. Understanding how activity volume affects tendon symptoms — and how to modify training rather than simply stop — is part of what a structured physio-led plan delivers.

The long-term data give grounds for confidence. A five-year cohort study found that roughly three-quarters of patients who completed a physio-based programme felt recovered, with substantial improvements in both pain during sport and VISA-P scores. The majority returned to their desired sport. That said, around one in four did not feel recovered at five years — an honest figure that sets the context for why injection and, in some cases, surgical options exist. Those pathways are explored in the sections that follow.

A minimum of three to six months of structured, progressive loading is typically needed before concluding that exercise rehabilitation alone has been adequately trialled. Duration and quality of the programme matter; a short or inconsistently applied course does not constitute a failed trial.

PRP and ESWT: what injection and shockwave can and cannot do

When three to six months of structured loading have not produced adequate recovery, the next consideration is an adjunctive treatment that acts directly on tendon tissue biology — the same local-pathology model that explains why loading programmes work in the first place. Two options have meaningful evidence behind them: platelet-rich plasma (PRP) injection and extracorporeal shockwave therapy (ESWT).

PRP injection

PRP is the best-evidenced injectable for this indication. The typical protocol involves three ultrasound-guided intratendinous injections of 5 ml, spaced one to two weeks apart. Prospective data confirm clinically meaningful improvements in symptoms and function alongside MRI-confirmed return to normal tendon architecture, with stable results reported to four-year follow-up. Ultrasound guidance is important — it ensures accurate delivery into the affected tissue rather than adjacent structures.

Focused ESWT

For patients who prefer a non-injection route, focused ESWT offers a well-evidenced alternative. A 2025 prospective cohort study examined four weekly shockwave sessions applied as monotherapy and found significant reductions in pain scores and improvements in VISA-P at treatment end and at three-month follow-up. Measurable structural changes were also recorded: reduced proximal tendon diameter and improved collagen fascicle organisation on ultrasound — direct evidence of tissue-level remodelling that reflects the local nature of the pathology.

Corticosteroid

Corticosteroid injection is not appropriate for patellar tendinopathy; it carries a recognised risk of tendon weakening and is not supported by evidence for this indication.

Timing the decision to inject

The UK Defence Rehabilitation Delphi consensus is clear that injections should not be applied automatically. Each case warrants individual consideration, with particular attention to long-term sporting and occupational demands. For a competitive athlete, the timing of an injection course — and the loading restrictions that follow — needs to be planned around the competition calendar rather than initiated reactively.

When surgery becomes the conversation

For the small proportion of patients who do not respond to a full course of loading — and where adjunctive treatment has also been tried without adequate gain — surgery enters the conversation. It remains an infrequent destination for this condition.

The procedures used are debridement (arthroscopic or open) and tenotomy: removing degenerate, structurally disorganised tendon tissue to stimulate a fresh healing response. The aim is not to repair a torn tendon. In chronic tendinopathy the tendon is often structurally intact but pathologically remodelled, and it is that degenerative zone which debridement addresses.

The evidence base here is thinner than for the physio or injection pathways. No head-to-head randomised trials have compared surgical techniques against each other, or against continued conservative care, in refractory patellar tendinopathy. The surgical literature for this condition consists largely of case series and expert opinion. In practice, decisions rest on clinical experience, careful review of everything already trialled, and shared decision-making between patient and consultant — not a published threshold or algorithm that determines who should proceed.

The five-year cohort data offer some clinical context for who reaches this point: the 9% of athletes who ceased sport entirely tended to have had higher baseline pain and disability at the outset. It is broadly this group — persistent, high-baseline pathology that has not adequately responded over a meaningful timeframe — for whom a surgical consultation becomes appropriate. Six months of structured, progressive loading is generally the minimum before that conversation begins, though the quality of the programme and any adjuncts trialled alongside it matter as much as duration alone.

How to read your own trajectory — and when to get assessed

Tracking your own progress gives you the clearest signal of whether conservative management is working. The VISA-P questionnaire — scored 0 to 100, where higher means better function — is the measure used across all the clinical trials discussed here, and it is straightforward to complete at home. A score in the mid-50s at baseline, improving toward the high 70s over several months, broadly matches the trajectory seen in athletes who went on to feel recovered at five years.

Two baseline factors predict a harder road: higher pain levels during loading and lower VISA-P scores at the outset — that is, worse function from the start. Neither forecloses recovery, but both suggest that waiting without reassessment is not a neutral choice.

"Adequate physio" has a specific meaning. It means a structured, progressively loaded programme — not general stretching, rest, or a handful of unsupervised exercises. Patients who feel they have tried physiotherapy but whose programme lacked progressive loading may not have completed a genuine trial. Three months of structured loading is a reasonable point to review progress; if VISA-P scores are not improving meaningfully by then, revisiting the programme before the six-month mark is sensible rather than premature.

One limitation worth naming: most rehabilitation trial data were gathered in predominantly male athlete cohorts. The prognostic figures in this article — recovery rates and VISA-P trajectories — may not apply equally to women, and that uncertainty should sit alongside any expectations about timeline.

If symptoms are not tracking in the right direction, or there is genuine uncertainty about whether a programme has been adequate, a consultant assessment can clarify the diagnosis and confirm what has actually been trialled. Lincolnshire Knee accepts patients without referral, with assessments available in Sleaford and Grantham.

The hierarchy across this condition remains consistent: structured loading first, with honest milestones; adjuncts only when those milestones go unmet; surgery only when everything else is documented as insufficient. Knowing where you stand in that sequence is the most practical thing to establish.

1. [1] Endogenous pain modulation is not different in basketball or volleyball athletes with patellar tendinopathy compared to asymptomatic athletic controls. (2025). https://doi.org/10.1016/j.msksp.2025.103280 https://doi.org/10.1016/j.msksp.2025.103280
2. [2] Patellar tendinitis (Wikipedia). https://en.wikipedia.org/?curid=2533397 https://en.wikipedia.org/?curid=2533397
3. [3] UK Defence Rehabilitation consensus agreement for the conservative management of Achilles and patellar tendinopathy: a modified Delphi approach. (2025). https://doi.org/10.1136/military-2024-002893 https://doi.org/10.1136/military-2024-002893
4. [4] Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar Tendinopathy: A Randomized Clinical Trial. (2025). https://doi.org/10.1111/sms.70186 https://doi.org/10.1111/sms.70186
5. [5] Long-term Prognosis of Athletes With Patellar Tendinopathy Receiving Physical Therapy: Patient-Reported Outcomes at 5-Year Follow-up. (2025). https://doi.org/10.1177/03635465251336466 https://doi.org/10.1177/03635465251336466
6. [6] ESWT is able to change macromorphological and micromorphological parameters in patellar tendinopathy: a prospective cohort study. (2025). https://doi.org/10.1097/JS9.0000000000002351 https://doi.org/10.1097/JS9.0000000000002351